Santa Ana Bio Announces the Appointment of Newman Yeilding as Chief Medical Officer
Santa Ana Bio, a precision immunology company developing targeted therapies for patients with autoimmune and inflammatory diseases, today announced the appointment of Newman Yeilding, M.D., as Chief Medical Officer.
Santa Ana Bio Announces the Appointment of Mike Bonney as Chair of the Board
Santa Ana Bio, Inc., a precision immunology company developing targeted therapies for patients with autoimmune and inflammatory diseases, today announced the appointment of Mike Bonney as Chair of its Board of Directors. Jerel Davis, Ph.D., Managing Director at Versant Ventures and Santa Ana’s founding Chairman, will remain a director.
